Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 24, 2012
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNATobias M Gorges, Johanna Schiller, Arndt Schmitz, et al.In Vivo (Athens, Greece)|January 2, 2023
Minimally Invasive Cytopathology and Accurate Diagnosis: Technical Procedures and Ancillary TechniquesConggai Huang, Xing Luo, Shaohua Wang, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2025
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-upSabine Zitzmann-Kolbe, Yvonne Remde, Ingrid Moen, et al.Heliyon|May 1, 2024
Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissuesStefan Salcher, Isabel Heidegger, Gerold Untergasser, et al.Microorganisms|April 27, 2024
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 VariantsChristoph Schatz, Ludwig Knabl, Hye Kyung Lee, et al.British Journal of Cancer|December 8, 2021
Exploiting mesothelin in thymic carcinoma as a drug delivery target for anetumab ravtansineVincent Chen, Shigeki Umemura, Yumin Han, et al.Cancers|April 3, 2021
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma TherapyStefanie Krassnig, Christina Wohlrab, Nicole Golob-Schwarzl, et al.Journal of Medicinal Chemistry|June 6, 2020
Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor ModelsUlrich Lücking, Lars Wortmann, Antje M Wengner, et al.Journal of Medicinal Chemistry|October 25, 2024
Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB InhibitorAntonius Ter Laak, Roman C Hillig, Steven J Ferrara, et al.Applied Clinical Informatics|September 11, 2024
Developing PRISM: A Pragmatic Institutional Survey and Bench Marking Tool to Measure Digital Research Maturity of Cancer CentersCarlos Berenguer Albiñana, Matteo Pallocca, Hayley Fenton, et al.Pageof 3